Company News

Evren Technologies receives FDA Breakthrough Device Designation for the Phoenix®

MedTech Innovator Selects Evren to Participate in the 2021 Showcase and Accelerator Program

Evren Technologies announces appointment of Robert V. House, Ph.D., as new director

THE EVREN TECHNOLOGIES TEAM HAS BEEN SELECTED AS 2021 ROSENMAN INNOVATORS

Evren Technologies Chosen to Present at the 2021 Bioelectronic Medicine Forum

Evren Technologies completes Phoenix® Pilot Study with Excellent Results